ekonominyheter

TranslateRSSMobil
Gilead Sciences Inc. Breathes a Sigh of Relief -- Hepatitis C Patients, Not So Much

Gilead Sciences Inc. Breathes a Sigh of Relief -- Hepatitis C Patients, Not So Much

Fool.com 11/11 10:52

Merck's new hepatitis C combination doesn't work all that well for short durations. Gilead Sciences' Harvoni is safe for now.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status